Testing effectiveness (Phase 2)WithdrawnNCT02342600
What this trial is testing
SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)
Who this might be right for
Gastrointestinal Stromal Tumors
Sarcoma Alliance for Research through Collaboration